Huidong Shi

11.9k citations
183 papers · 8.8k indexed · 1 hit paper · h-index 51
Topics
Epigenetics and DNA Methylation (70 papers)RNA modifications and cancer (37 papers)Cancer-related gene regulation (21 papers)

In The Last Decade

Huidong Shi

173 papers receiving 8.7k citations

Hit Papers

Activation of Gpr109a, Receptor for Niacin and the Commen...2014202620182022201450010001.5k

Peers

Huidong Shi
Comparison fields: 5 of 154
  • Molecular Biology 6.2k
  • Immunology 1.3k
  • Oncology 1.2k
  • Genetics 1.1k
  • Cancer Research 1.1k
Replace Hui Liu with:
Hui Liu China
Feng Jin China
Ferdinando Nicoletti Italy
Frank J. T. Staal Netherlands
Christos Tsatsanis Greece
Wei Li China
Krishna R. Kalari United States
Alastair J.M. Watson United Kingdom
Derek A. Mann United Kingdom
Yu Chen United States
Huidong Shi relative to Hui Liu China Hui Liu's profile →
Citations per field
00.5×1.5×
Hui Liu · 1×
Citations per year

Countries citing papers authored by Huidong Shi

Since Specialization
Citations

This map shows the geographic impact of Huidong Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huidong Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huidong Shi more than expected).

Fields of papers citing papers by Huidong Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huidong Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huidong Shi. The network helps show where Huidong Shi may publish in the future.

Co-authorship network of co-authors of Huidong Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Huidong Shi. A scholar is included among the top collaborators of Huidong Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huidong Shi. Huidong Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 3
4 0
5 1
6 2
7 9
8 30
9 36
10 17
11 56
12 61
13 141
14 50
15 10
16 23
17 69
18 117
19 178
20 109

About Huidong Shi

Huidong Shi is a scholar working on Genetics, Molecular Biology and Biological Psychiatry, having authored 183 papers that have together received 8.8k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (70 papers), RNA modifications and cancer (37 papers) and Cancer-related gene regulation (21 papers). The work is most often cited by research in Molecular Biology (6.2k citations), Biological Psychiatry (222 citations) and Cancer Research (1.1k citations). Huidong Shi has collaborated with scholars based in United States, China and Georgia. Frequent co-authors include David H. Munn, Pearlly S. Yan, Muthusamy Thangaraju, Vadivel Ganapathy, Charles W. Caldwell, Nagendra Singh, Puttur D. Prasad, Santhakumar Manicassamy, Ravi N. Padia and Ashish Gurav. Their work appears in journals such as Nucleic Acids Research, Circulation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026